(Q37267741)

19 August 2017

A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention (English)

1 reference

19 August 2017

0 references

0 references

7

Thomas Ten Have

1 reference

19 August 2017

1

David W Oslin

1 reference

19 August 2017

Helen Marie Pettinati

3

object named as

Helen M Pettinati

1 reference

19 August 2017

Kevin G Lynch

2

1 reference

19 August 2017

Kyle M Kampman

4

1 reference

19 August 2017

Peter Gariti

5

1 reference

19 August 2017

Lois Gelfand

6

1 reference

19 August 2017

Shoshana Wortman

8

1 reference

19 August 2017

William Dundon

9

1 reference

19 August 2017

Charles Dackis

10

1 reference

19 August 2017

Joseph R Volpicelli

11

1 reference

19 August 2017

Charles P O'Brien

12

1 reference

19 August 2017

1 July 2008

1 reference

Alcoholism: Clinical and Experimental Research

19 August 2017

1 reference

19 August 2017

32

1 reference

19 August 2017

1299-1308

1 reference

19 August 2017

7

1 reference

Developing adaptive treatment strategies in substance abuse research

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

A conceptual framework for adaptive preventive interventions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Simple pattern-mixture models for longitudinal data with missing observations: analysis of urinary incontinence data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Naltrexone in the treatment of alcohol dependence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

New methodologies for pharmacological treatment trials for alcohol dependence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Naltrexone for alcohol dependence: a randomized controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Predicting treatment response to naltrexone: the influence of craving and family history

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3812909

Naltrexone and alcohol dependence. Role of subject compliance

3 September 2018

1 reference

12 December 2020

Naltrexone as an adjunctive treatment for older patients with alcohol dependence

1 reference

12 December 2020

Random effects logistic models for analysing efficacy of a longitudinal randomized treatment with non-adherence

1 reference

12 December 2020

Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics

1 reference

12 December 2020

Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients

1 reference

12 December 2020

Estimating treatment effects in randomized clinical trials in the presence of non-compliance

1 reference

12 December 2020

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse

1 reference

12 December 2020

Reliability of a Timeline Method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations

1 reference

12 December 2020

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

12 December 2020

Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH Three-Year Drinking Outcomes

1 reference

12 December 2020

Naltrexone in the treatment of alcohol dependence

1 reference

12 December 2020

10.1111/J.1530-0277.2008.00698.X

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference